About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013 1 (May 31, 2013)

handle is hein.congrec/cbo11150 and id is 1 raw text is: CONGRESSIONAL BUDGET OFFICE
0o                               COST ESTIMATE
May 31, 2013
H.R. 1919
Safeguarding America's Pharmaceuticals Act of 2013
As ordered reported by the House Committee on Energy and Commerce on May 15, 2013
SUMMARY
H.R. 1919 would require the Food and Drug Administration (FDA) to establish national
standards for monitoring the movement of prescription drugs through the drug
distribution system. The drug distribution system encompasses the network of
companies that produce, handle, distribute, and dispense drug products. The legislation
would impose new regulatory requirements on such companies relating to the handling of
drug products and recordkeeping of transactions, and would create notification rules
concerning drugs that are potentially unsuitable for distribution.
The bill also would require the FDA to establish a licensing program for certain third
parties that provide logistic services to support pharmaceutical manufacturers,
wholesalers, and dispensers. The bill would authorize FDA to collect and spend fees to
cover the costs of the licensing program.
CBO estimates that enacting H.R. 1919 would increase federal revenues by $19 million
over the 2015-2018 period and by $24 million over the 2015-2023 period. Pay-as-you-go
procedures apply because enacting the legislation would affect revenues.
CBO estimates that implementing H.R. 1919 would have a discretionary cost of
$39 million over the 2014-2018 period, assuming annual appropriation actions consistent
with the bill.
H.R. 1919 would impose both intergovernmental and private-sector mandates as defined
in the Unfunded Mandates Reform Act (UMRA) by requiring public and private-sector
entities to comply with standards for monitoring the movement of prescription drugs
through the distribution system. Because few public entities manufacture, distribute, or
dispense prescription drugs, CBO estimates that the costs to public entities to comply
with the mandates in the bill would be small and below the intergovernmental threshold
established in UMRA ($75 million in 2013, adjusted annually for inflation). CBO

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most